St. Jude Medical Enrolls First Patient in EnligHTN II Renal Denervation Study

January 30, 2013
St. Jude Medical announced enrollment of the first patient in the EnligHTN II trial. The company said that the post-market clinical study will further evaluate the safety and efficacy of the EnligHTN Renal Denervation System in patients with uncontrolled hypertension.
RTT News